COTEMPLA XR-ODT 8.6 MG TABLET
FDA nonproprietary name: methylphenidate
For 30 tablets
Pharmacies pay
$541.47 filed
30 × $18.04904 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$499.49 filed
30 × $16.64974 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
0.92× estimated
Medicare paid 8% less than pharmacies pay.
Part D averages every strength and form sold under “Cotempla XR-ODT” / “Methylphenidate” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$627.69 estimated
$541.47 + $81.22 (15%) + $5.00 fee per fill = $627.69
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
COTEMPLA XR-ODT 8.6 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as methylphenidate, under the trade name “Cotempla XR-ODT”.
FDA gives its dosage form as tablet, orally disintegrating and its route as oral.
The labeler, the company named on the label, is Neos Therapeutics Brands, LLC.
FDA’s Established Pharmacologic Class for it is Central Nervous System Stimulant.
The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 70165-0100-30.
NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $541.47 for 30 tablets (30 × $18.04904 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The NDC
- 70165-0100-30 · Neos Therapeutics Brands, LLC · $18.04904 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
10 other products in the NADAC file share the FDA nonproprietary name methylphenidate with COTEMPLA XR-ODT 8.6 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| COTEMPLA XR-ODT 8.6 MG TABLET this page | $18.04904 per EA filed | $16.64974 per EA filed |
| COTEMPLA XR-ODT 17.3 MG TABLET | $17.89343 per EA filed | $16.64974 per EA filed |
| COTEMPLA XR-ODT 25.9 MG TABLET | $17.97122 per EA filed | $16.64974 per EA filed |
| METHYLPHENIDATE 10 MG/9 HR PATCH | $6.66369 per EA filed | $9.71315 per EA filed |
| METHYLPHENIDATE 15 MG/9 HR PATCH | $6.63292 per EA filed | $9.71315 per EA filed |
| METHYLPHENIDATE 20 MG/9 HR PATCH | $6.60924 per EA filed | $9.71315 per EA filed |
| METHYLPHENIDATE 30 MG/9 HR PATCH | $7.25282 per EA filed | $9.71315 per EA filed |
| METHYLPHENIDATE ER(LA) 10 MG CP | $2.39986 per EA filed | $3.41274 per EA filed |
| METHYLPHENIDATE ER(LA) 20 MG CP | $1.69545 per EA filed | $3.41274 per EA filed |
| METHYLPHENIDATE ER(LA) 30 MG CP | $1.90366 per EA filed | $3.41274 per EA filed |
| METHYLPHENIDATE ER(LA) 40 MG CP | $1.85373 per EA filed | $3.41274 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
Its NADAC price is $18.04904 per EA filed.
Of the 203 other products in FDA’s Central Nervous System Stimulant class priced per EA, 9 have a higher middle NADAC price and 194 a lower one. The one in the middle is LISDEXAMFETAMINE 20 MG TB CHEW, at $4.33791 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $499.49 for 30 tablets, at an average of $16.64974 per EA in 2024 (2024-01-01 to 2024-12-31) for “Cotempla XR-ODT” and “Methylphenidate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 238 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for COTEMPLA XR-ODT 8.6 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Cotempla XR-ODT / Methylphenidate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.
Related pages
Its pharmacologic class
Related in the same class
- METHYLPHENIDATE ER 10 MG TAB
- VYVANSE 10 MG CAPSULE
- DEXTROAMPHETAMINE 10 MG TAB
- BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE
- DEXMETHYLPHENIDATE ER 10 MG CP